Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · IEX Real-Time Price · USD
0.280
-0.015 (-5.12%)
At close: Apr 19, 2024, 4:00 PM
0.282
+0.002 (0.75%)
After-hours: Apr 19, 2024, 6:13 PM EDT

Daré Bioscience Statistics

Total Valuation

DARE has a market cap or net worth of $28.16 million. The enterprise value is $17.93 million.

Market Cap 28.16M
Enterprise Value 17.93M

Important Dates

The next estimated earnings date is Thursday, May 9, 2024, before market open.

Earnings Date May 9, 2024
Ex-Dividend Date n/a

Share Statistics

DARE has 100.58 million shares outstanding. The number of shares has increased by 3.23% in one year.

Shares Outstanding 100.58M
Shares Change (YoY) +3.23%
Shares Change (QoQ) -3.85%
Owned by Insiders (%) 1.65%
Owned by Institutions (%) 6.61%
Float 98.89M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 10.03
Forward PS 6.60
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 6.38
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.86

Current Ratio 0.86
Quick Ratio 0.61
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -120.80%
Return on Capital (ROIC) n/a
Revenue Per Employee $122,082
Profits Per Employee -$1.31M
Employee Count 23
Asset Turnover 0.11
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -72.28% in the last 52 weeks. The beta is 1.21, so DARE's price volatility has been higher than the market average.

Beta (1Y) 1.21
52-Week Price Change -72.28%
50-Day Moving Average 0.46
200-Day Moving Average 0.49
Relative Strength Index (RSI) 28.13
Average Volume (30 Days) 438,579

Short Selling Information

The latest short interest is 235,035, so 0.23% of the outstanding shares have been sold short.

Short Interest 235,035
Short Previous Month 456,200
Short % of Shares Out 0.23%
Short % of Float 0.24%
Short Ratio (days to cover) 0.68

Income Statement

In the last 12 months, DARE had revenue of $2.81 million and -$30.16 million in losses. Loss per share was -$0.35.

Revenue 2.81M
Gross Profit 2.81M
Operating Income -30.94M
Pretax Income -30.16M
Net Income -30.16M
EBITDA -30.07M
EBIT -30.16M
Loss Per Share -$0.35
Full Income Statement

Balance Sheet

The company has $11.64 million in cash and $1.40 million in debt, giving a net cash position of $10.24 million or $0.10 per share.

Cash & Cash Equivalents 11.64M
Total Debt 1.40M
Net Cash 10.24M
Net Cash Per Share $0.10
Equity / Book Value -5.05M
Book Value Per Share -0.05
Working Capital -2.94M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$38.86 million and capital expenditures -$629,430, giving a free cash flow of -$39.49 million.

Operating Cash Flow -38.86M
Capital Expenditures -629,430
Free Cash Flow -39.49M
FCF Per Share -$0.45
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -1,101.89% and -1,074.17%.

Gross Margin 100.00%
Operating Margin -1,101.89%
Pretax Margin -1,074.17%
Profit Margin -1,074.17%
EBITDA Margin -1,070.88%
EBIT Margin -1,074.17%
FCF Margin -1,406.26%

Dividends & Yields

DARE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.23%
Shareholder Yield -3.23%
Earnings Yield -107.10%
FCF Yield -140.21%

Analyst Forecast

The average price target for DARE is $6.00, which is 2,042.86% higher than the current price. The consensus rating is "Buy".

Price Target $6.00
Price Target Difference 2,042.86%
Analyst Consensus Buy
Analyst Count 2
Revenue Growth Forecast (5Y) 154.66%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on July 20, 2017. It was a reverse split with a ratio of 1:10.

Last Split Date Jul 20, 2017
Split Type Reverse
Split Ratio 1:10

Scores

DARE has an Altman Z-Score of -15.33. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -15.33
Piotroski F-Score n/a